Navigation Links
Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
Date:2/7/2008

uisitions, and, in general, anticipated financial results for 2008. Actual performance and benefits results may differ materially from those set forth in this press release due to risks and uncertainties inherent in Digirad's business including, without limitation, changes in business conditions, technology, customers' business conditions, work force, suppliers, business prospects, economic outlook, operational policy or structure, acceptance and use of Digirad's camera systems and services, reliability, recalls, and other risks detailed in Digirad's filings with the U.S. Securities and Exchange Commission, including Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Form 8-K and other reports. Readers are cautioned to not place undue reliance on these forward looking statements, which speak only as of the date hereof. All forward looking statements are qualified in their entirety by this cautionary statement, and Digirad undertakes no obligation to revise or update the forward looking statements contained herein.

Digirad Corporation

Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

Three Months Ended Twelve Months Ended

December 31, December 31,

2007 2006 2007 2006

(unaudited) (unaudited)

Revenues:

DIS $13,420 $11,606 $52,440 $49,614

Product 5,403 5,641 21,507 22,312

Total revenues 18,823 17,247 73,947 71,926

Cost of revenues:

DIS 10,749 8,595 39,520 37,675

Product 3,582 3,742 13,909 15,192

Total cost of revenues 14,331
'/>"/>

SOURCE Digirad Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy
2. Finkelstein Thompson LLP Announces Filing of Securities Fraud Class Action Against CellCyte Genetics Corporation
3. DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results
4. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
5. CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology
6. DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call
7. Baxa Corporation Launches New Web Site
8. CuraGen Corporation Receives Notification from NASDAQ
9. Healionics Corporation Completes Series A Financing
10. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
11. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 Global Stem Cells Group ... Bioquark, Inc.’s biologic products for the regeneration and repair of ... Global Stem Cells Group’s ambitious expansion plans in Latin America, ... access to regenerative medicine and stem cell therapies. , ... biologics that have the ability to alter the regulatory state ...
(Date:6/2/2015)... , June 02, 2015 Research and Markets( ... "Molecular Diagnostics - Global Market Size, Strategy and Forecasts ... "Molecular Diagnostics - Global Market Size, Strategy ... analysts and planners can use. Hundreds of pages of ... States Medicare Fee Payment Schedules to help understand test ...
(Date:6/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/l5jcdk/genotyping_market ) has announced ... Application & by Products - Global Forecast to 2020" ... genotyping market is expected to reach $17.0 Billion in ... of 22.3% during the forecast period of 2015 to ... the availability of a range of products for wide ...
(Date:6/2/2015)... June 2, 2015   Y-Prime, Inc ., ... BIO Exhibition 2015 in Philadelphia ... largest biotechnology gathering, allows influential decision makers from ... they can evaluate emerging technologies such as YPrime. ... in the design, implementation and management of Interactive ...
Breaking Biology Technology:Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells 2Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells 3Global Molecular Diagnostics Report 2015-2019 - Market Size, Strategy and Forecasts 2Global Molecular Diagnostics Report 2015-2019 - Market Size, Strategy and Forecasts 3Genotyping Market Report 2015 by Technology, Application & by Products - Global Forecast to 2020 for the $17 Billion Market 2YPrime at BIO Exhibition in Philadelphia and DIA in Washington DC during the month of June 2
... , , Cleveland Clinic initiates ... , CALGARY, Dec. 22 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" ... begun dosing patients in its US Phase 2 clinical ... RVX-208, Resverlogix,s oral small molecule therapy for the treatment ...
... , SHANGHAI, Dec. 22 /PRNewswire-Asia/ ... China, announced today that,the company has received 2009 Deloitte Technology ... to win this award. The news was,announced at a ceremony ... , The Deloitte Technology Fast 500 ...
... , LEIDEN, The Netherlands, ... an intensive care unit will,in the future most likely be ... the result of a study conducted by the Dutch Top,Institute ... Erasmus Medical Centre/Sophia Children,s Hospital (Prof D. Tibboel),are represented. , ...
Cached Biology Technology:Resverlogix Commences Phase 2 Atherosclerosis Clinical Trial 2Resverlogix Commences Phase 2 Atherosclerosis Clinical Trial 3Resverlogix Commences Phase 2 Atherosclerosis Clinical Trial 4Research: Dosage of Morphine for ill Newborns Still too Imprecise 2
(Date:4/27/2015)... Apr. 27, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... pre-order customers the first week of May, 2015 and ... of May. Gino Pereira , ... for the company as Wocket® enters the consumer market. ...
(Date:4/20/2015)... The announcement comes as demand for fire ... Ireland,s foremost records management company, has ... an impressive track record of clients within the first 12 ... management sector in Dubai . As a ... employ a further eight staff members at its Irish headquarters. ...
(Date:4/13/2015)... , April 13, 2015 ... TechSci Research, "Global Biometrics Market Forecast & Opportunities, 2020", ... a CAGR of around 14% till 2020. The ... for large scale implementation and review of biometric ... launch of new products with greater efficiency, are ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... method for increasing solubility (the ability of one ... graduate student at the Hebrew University of Jerusalem ... commercial benefits for industry, particularly in pharmaceuticals, cosmetics ... Margulis-Goshen, a Ph.D. student of Prof. Shlomo Magdassi, ...
... New Year approaches, resolutions of losing weight and getting ... with so many different fad diets, experts, websites and ... of how to maintain a healthy lifestyle, accomplishing your ... decades we,ve seen a dietary shift," said Donald Moore, ...
... Denmark A comprehensive framework to encourage and facilitate the ... journal. The 24 recommendations of the GBIF Data Publishing ... BMC Bioinformatics . Some of the ... up by GBIF and others, including the publication of ...
Cached Biology News:Prize-winning research on solubility by Hebrew University doctoral student yields promise 2Ring in the New Year with dairy 2New biodiversity data publishing framework proposed 2New biodiversity data publishing framework proposed 3
NANS Immunogen: NANS (NP_061819, 260 a.a. ~ 360 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
ANTI-RAT ADHESION MARKERS, CDs, CYTOKINES, ETC Rat ICAM PE - Mouse IgG1...
Rabbit monoclonal [E227] to ZAP70 (phospho Y319) ( Abpromise for all tested applications). Antigen: Synthetic phospho peptide corresponding to residues surrounding Tyr319 of human ZAP70 Entre...
Rabbit polyclonal to Bag5 ( Abpromise for all tested applications). entrezGeneID: 9529 SwissProtID: Q9UL15...
Biology Products: